Joi B Carter, MD

Title(s)
Associate Professor of Dermatology
Additional Titles/Positions/Affiliations
Director of High Risk Skin Cancer Clinic
Dermatology Residency Program Director
Vice Chair of Education - Dept of Dermatology
Department(s)
Dermatology
Education
College of the Holy Cross, Worcester, MA
B.A.
Dartmouth Medical School, Hanover, NH
M.D.
Beth Israel Deaconess Medical Center
Internship- Internal Medicine
Dartmouth-Hitchcock Medical Center
Residency- Dermatology
Brigham and Women’s Hospital and Dana Farber Cancer Institute
Fellowship- Cutaneous Oncology
Programs
Dartmouth Cancer Center
Websites
https:
https:
Contact Information
Dartmouth-Hitchcock Heater Road
18 Old Etna Road, Level 3
Lebanon NH
Office: 603-650-3100
Professional Interests
Cutaneous Oncology
Cutaneous T cell lymphoma
Cutaneous B cell lymphoma
High risk skin cancer
Cutaneous care of transplant recipients
Melanoma
Secondary cutaneous marginal zone lymphoma arising in association with a Mohs micrographic surgery graft site. Primary Cutaneous CD30-Positive Lymphoproliferative Disorder With Gamma-Delta T-Cells: A Molecular-Annotated Case With a Classic Clinical Appearance and Behavior. Adjuvant Radiation is Associated With Reduced Risks of Local Recurrence and Nodal Metastasis in High-Risk Localized Cutaneous Squamous Cell Carcinoma: A Retrospective Multicenter Cohort Study. Risk of recurrence, metastasis, and death for cutaneous squamous cell carcinomas with solitary large caliber perineural invasion: A multicenter cohort study. Patterns of disease-specific death from cutaneous squamous cell carcinoma: A multicenter retrospective cohort. Recurrent status is associated with poor outcomes in cutaneous squamous cell carcinoma. Papules confined to black-ink tattoos. Dermatology Scheduling Triage of Transplant Patients and Transplant Candidates to Improve Early Diagnosis and Prevention of Skin Cancer: International Immunosuppression and Transplant Skin Cancer Collaborative Expert Consensus Recommendations. Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell Carcinoma. Impact of immunosuppression on cutaneous squamous cell carcinoma outcomes. |
|